- Home
- XYF vs TARA Comparison
XYF vs TARA Comparison
Compare XYF & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XYF | TARA |
|---|---|---|
| Founded | 2014 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.3M | 268.5M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | XYF | TARA |
|---|---|---|
| Price | $3.45 | $5.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $21.67 |
| AVG Volume (30 Days) | 116.5K | ★ 954.8K |
| Earning Date | 03-25-2026 | 03-10-2026 |
| Dividend Yield | ★ 12.13% | N/A |
| EPS Growth | N/A | ★ 38.25 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,948,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.90 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.25 | $2.77 |
| 52 Week High | $20.36 | $7.82 |
Technical Indicators
Market Signals| Indicator | XYF | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 25.52 | 41.19 |
| Support Level | N/A | $4.95 |
| Resistance Level | $5.07 | $5.39 |
| Average True Range (ATR) | 0.30 | 0.29 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 1.80 | 24.63 |
Price Performance
Historical ComparisonAbout XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).